文献速递肝病消化道肿瘤与早癌

糖尿病、血糖与脂肪肝、肝硬化及肝癌发病风险:50万人前瞻性研究

Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.
PubMed 文献 · Hepatology · 2018-01-01

中国慢性病前瞻性研究纳入512891名成人,随访10年,记录503993名基线无癌症或慢性肝病者的肝癌、肝硬化、非酒精性脂肪性肝病(NAFLD)和酒精性肝病(ALD)住院病例。基线5.8%患糖尿病,糖尿病者肝癌、肝硬化、NAFLD、ALD风险均升高;未诊断糖尿病者随机血糖升高亦与这些肝病风险正相关,且关联不因乙型肝炎病毒感染而异。

要点

  • 糖尿病者肝癌风险升高(HR 1.49),肝硬化、NAFLD、ALD风险亦升高。
  • 未诊断糖尿病者随机血糖每升高1 mmol/L,肝癌等肝病风险轻度升高。
  • 糖尿病与肝病的关联不因乙型肝炎病毒感染状态而不同。

核心结论

  • 中国成人中,糖尿病及未诊断糖尿病者的较高血糖水平与肝癌和主要慢性肝病风险升高相关。

研究设计与样本

  • 前瞻性中国慢性病前瞻性研究(China Kadoorie Biobank)纳入512891名成人,基线无癌症或慢性肝病者503993名,随访10年。

主要发现

  • 随访10年记录肝癌2568例、肝硬化2082例、NAFLD住院1298例、ALD住院244例。
  • 基线5.8%患糖尿病;糖尿病者肝癌调整HR 1.49(95%CI 1.30-1.70),肝硬化1.81(1.57-2.09),NAFLD 1.76(1.47-2.16),ALD 2.24(1.42-3.54)。
  • 未诊断糖尿病者随机血糖每升高1 mmol/L,肝癌调整HR 1.04(1.03-1.06),肝硬化1.07(1.05-1.09),NAFLD 1.07(1.05-1.10),ALD 1.10(1.05-1.15)。
  • 糖尿病与肝病的关联不因乙型肝炎病毒感染状态而异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The prevalence of diabetes is increasing rapidly in China. However, evidence is limited about its effects on chronic liver diseases and liver cancer. We examined the associations of diabetes with chronic liver diseases and liver cancer and of random plasma glucose (RPG) with these liver diseases among participants without diabetes in Chinese adults and the possible interaction by hepatitis B virus (HBV) infection. The prospective China Kadoorie Biobank recruited 512,891 adults. During 10 years of follow-up, 2,568 liver cancer, 2,082 cirrhosis, 1,298 hospitalized nonalcoholic fatty liver disease (NAFLD), and 244 hospitalized alcoholic liver disease (ALD) cases were recorded among 503,993 participants without prior history of cancer or chronic liver diseases at baseline. Cox regression was used to estimate hazard ratios (HRs) for each disease by diabetes status (previously diagnosed or screen-detected) and, among those without previously diagnosed diabetes, by levels of RPG. Overall 5.8% of participants had diabetes at baseline. Compared to those without diabetes, individuals with diabetes had adjusted HRs of 1.49 (95% confidence interval 1.30-1.70) for liver cancer, 1.81 (1.57-2.09) for cirrhosis, 1.76 (1.47-2.16) for NAFLD, and 2.24 (1.42-3.54) for ALD. The excess risks decreased but remained elevated in those with longer duration. Among those without previously diagnosed diabetes, RPG was positively associated with liver diseases, with adjusted HRs per 1 mmol/L higher RPG of 1.04 (1.03-1.06) for liver cancer, 1.07 (1.05-1.09) for cirrhosis, 1.07 (1.05-1.10) for NAFLD, and 1.10 (1.05-1.15) for ALD. These associations did not differ by HBV infection. CONCLUSION: In Chinese adults, diabetes and higher blood glucose levels among those without known diabetes are associated with higher risks of liver cancer and major chronic liver diseases.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Pang Y, Kartsonaki C, Turnbull I, et al. Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People. Hepatology. 2018. PMID: 29734463. doi:10.1002/hep.30083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。